Literature DB >> 23604467

A pilot study comparing protein expression in different segments of the normal colon and rectum and in normal colon versus adenoma in patients with Lynch syndrome.

Chongjuan Wei1, Jinyun Chen, Mala Pande, Patrick M Lynch, Marsha L Frazier.   

Abstract

PURPOSE: Lynch syndrome (LS) is a common inherited predisposition to colorectal cancer (CRC). In LS patients, CRC is predominantly located in the right colon, as opposed to sporadic CRC, which usually affects the left colon or rectum. Previous studies have demonstrated a clear distinction in gene expression between sporadic CRC and normal colon at different locations in the colorectum. However, little is known about LS gene expression profiles in different areas of the colorectum. Here, we compared the protein expression profiles for normal colorectal samples among different locations as well as between adenomas and matched normal tissue in LS.
METHODS: Protein from 33 tissue samples (27 normal tissues and 6 adenomas) from 9 patients with LS was extracted for reverse-phase protein array (RPPA) analysis. The antibody panel used for RPPA included 109 key proteins involved in various cancer-related pathways. Cluster 3.0 was used for unsupervised and supervised clustering analysis.
RESULTS: IGF1R and COL6A1 were expressed significantly differently between the normal right and normal left colon (q < 0.05); FN1, COL6A1, and IGF1R were expressed significantly differently between the normal right colon and normal rectum (q < 0.05). In the adenomas and matched normal tissue, PEA-15 was the only protein with significantly different expression (q < 0.05).
CONCLUSION: We found differences in protein expression between normal tissues from the right colon, left colon, and rectum as well as between adenomas and matched normal tissue. However, those differences should be further confirmed in a larger sample size.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23604467      PMCID: PMC3708474          DOI: 10.1007/s00432-013-1437-x

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  37 in total

1.  Loss of expression of DNA mismatch repair proteins in aberrant crypt foci identified in vivo by magnifying colonoscopy in subjects with hereditary nonpolyposic and sporadic colon rectal cancer.

Authors:  Miguel Angel Ramírez-Ramírez; Sergio Sobrino-Cossío; José Guillermo de la Mora-Levy; Angélica Hernández-Guerrero; Verónica de Jesús Macedo-Reyes; Héctor Aquiles Maldonado-Martínez; Juan Octavio Alonso-Larraga; Mauro Eduardo Ramírez-Solis
Journal:  J Gastrointest Cancer       Date:  2012-06

Review 2.  Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location.

Authors:  J A Bufill
Journal:  Ann Intern Med       Date:  1990-11-15       Impact factor: 25.391

3.  Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.

Authors:  Mala Pande; Chongjuan Wei; Jinyun Chen; Christopher I Amos; Patrick M Lynch; Karen H Lu; Laura A Lucio; Stephanie G Boyd-Rogers; Sarah A Bannon; Maureen E Mork; Marsha L Frazier
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

4.  Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation.

Authors:  F E M Rijcken; H Hollema; J H Kleibeuker
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

5.  Distinguishing right from left colon by the pattern of gene expression.

Authors:  Oleg K Glebov; Luz M Rodriguez; Kenneth Nakahara; Jean Jenkins; Janet Cliatt; Casey-Jo Humbyrd; John DeNobile; Peter Soballe; Richard Simon; George Wright; Patrick Lynch; Sherri Patterson; Henry Lynch; Steven Gallinger; Aby Buchbinder; Gary Gordon; Ernest Hawk; Ilan R Kirsch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-08       Impact factor: 4.254

Review 6.  Are there two sides to colorectal cancer?

Authors:  Barry Iacopetta
Journal:  Int J Cancer       Date:  2002-10-10       Impact factor: 7.396

7.  Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells.

Authors:  C Hao; F Beguinot; G Condorelli; A Trencia; E G Van Meir; V W Yong; I F Parney; W H Roa; K C Petruk
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

8.  Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells.

Authors:  Chang Xiao; Bao Feng Yang; Neda Asadi; Francesco Beguinot; Chunhai Hao
Journal:  J Biol Chem       Date:  2002-04-25       Impact factor: 5.157

9.  Different age and sex relationship for cancer of subsites of the large bowel.

Authors:  O M Jensen
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640

10.  Differences in the expression of mucus-associated antigens between proximal and distal human colon adenocarcinomas.

Authors:  J Bara; J Nardelli; C Gadenne; M Prade; P Burtin
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

View more
  3 in total

1.  Evaluation of the RAS signaling network in response to MEK inhibition using organoids derived from a familial adenomatous polyposis patient.

Authors:  Hiroki Osumi; Atsushi Muroi; Mizuho Sakahara; Hiroshi Kawachi; Takuya Okamoto; Yasuko Natsume; Hitomi Yamanaka; Hiroshi Takano; Daisuke Kusama; Eiji Shinozaki; Akira Ooki; Kensei Yamaguchi; Masashi Ueno; Kengo Takeuchi; Tetsuo Noda; Satoshi Nagayama; Naohiko Koshikawa; Ryoji Yao
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

2.  Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers.

Authors:  Maja Ludvigsen; Louise Thorlacius-Ussing; Henrik Vorum; Mogens Tornby Stender; Ole Thorlacius-Ussing; Bent Honoré
Journal:  Curr Issues Mol Biol       Date:  2021-09-02       Impact factor: 2.976

Review 3.  Organoids and Colorectal Cancer.

Authors:  Antonio Barbáchano; Asunción Fernández-Barral; Pilar Bustamante-Madrid; Isabel Prieto; Nuria Rodríguez-Salas; María Jesús Larriba; Alberto Muñoz
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.